A company insider recently bought 30,000 shares of Applied Therapeutics Inc [APLT]. Should You Buy?

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Applied Therapeutics Inc shares valued at $65,367 were purchased by Kanter Stacy J. on Dec 01. At $2.18 per share, Kanter Stacy J. acquired 30,000 shares. The insider’s holdings grew to 63,000 shares worth approximately $0.17 million following the completion of this transaction.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Also, Shendelman Shoshana sold 3,968 shares, netting a total of over 7,817 in proceeds. Following the sale of shares at $1.97 each, the insider now holds 2,596,387 shares.

Before that, Perfetti Riccardo had sold 1,583 shares from its account. In a trade valued at $3,119, the Chief Medical Officer traded Applied Therapeutics Inc shares for $1.97 each. Upon closing the transaction, the insider’s holdings decreased to 1,583 shares, worth approximately $1.86 million.

As published in a research note from Barclays on January 04, 2022, Applied Therapeutics Inc [APLT] has been rated down from an Overweight to an Equal weight and the price target has been revised to $7 from $44.

Analyzing APLT Stock Performance

During the last five days, there has been a drop of approximately -4.29%. Over the course of the year, Applied Therapeutics Inc shares have dropped approximately -20.00%. Shares of the company reached a 52-week high of $4.42 on 01/03/24 and a 52-week low of $1.85 on 01/08/24. A 50-day SMA is recorded $2.86, while a 200-day SMA reached $2.05. Nevertheless, trading volume fell to 1.59 million shares from 0.8 million shares the previous day.

Support And Resistance Levels for Applied Therapeutics Inc (APLT)

According to the 24-hour chart, there is a support level at 2.58, which, if violated, would cause prices to drop to 2.49. In the upper region, resistance lies at 2.78. The next price resistance is at 2.88. RSI (Relative Strength Index) is 45.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.17, which suggests the price will decrease in the coming days. Percent R is at 85.04%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Applied Therapeutics Inc subject to short interest?

Stocks of Applied Therapeutics Inc saw a sharp rise in short interest on Jan 31, 2024 jumping by 1.73 million shares to 3.71 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2023 was 1.98 million shares. A jump of 46.63% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.8 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.8.

Most Popular